Mylan Gets One Of Pfizer's Norvasc Patents Tossed
U.S. District Judge Terrence F. McVerry granted Mylan’s motion to dismiss U.S. Patent No. 4,572,909 from the case for lack of subject matter jurisdiction on Wednesday. The ‘909 patent expired on July 31, 2006.
Thursday, Pfizer spokesperson Bryan Haskins downplayed the significance of the development,...
To view the full article, register now.